HOME › DRUGS › PEGAPTANIB
ACTIVE SUBSTANCE / INN

PEGAPTANIB

Brand name(s): Macugen
EMA LISTED
WITHDRAWN
Wet Macular Degeneration
ACTIVE SUBSTANCE
Pegaptanib
REGULATORS
EMA
SPONSORS / MAH
PharmaSwiss Ceska Republika s.r.o
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
MacugenPharmaSwiss Ceska Republika s.r.oWithdrawn31/01/2006Wet Macular Degeneration

FULL INTELLIGENCE ON PEGAPTANIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →